Occudo Quantitative Strategies’s Axonics, Inc. Common Stock AXNX Stock Holding History

Occudo Quantitative Strategies’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-30,820	Closed	-$1.56M	–	1376
2023 Q2	$1.56M	Buy	+30,820	New	+$1.64M	0.16%	193
2022 Q4	–	Sell	-8,353	Closed	-$588K	–	1451
2022 Q3	$588K	Buy	+8,353	New	+$576K	0.05%	607
2021 Q4	–	Sell	-6,839	Closed	-$445K	–	1286
2021 Q3	$445K	Buy	+6,839	New	+$467K	0.05%	583

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Occudo Quantitative Strategies's AXNX Position: Q3 2023 in Review

Occudo Quantitative Strategies sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2023, closing a stake of 30,820 shares — an estimated $1.56M sold.

Occudo Quantitative Strategies first reported a position in AXNX in Q3 2021 and held it in 3 quarters. The position peaked at $1.56M in Q2 2023. 220 funds tracked by Wall St. Rank hold AXNX as of Q3 2023.

Occudo Quantitative Strategies reported no remaining Axonics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Occudo Quantitative Strategies sold 30,820 Axonics, Inc. Common Stock shares in Q3 2023, an estimated $1.56M.
Occudo Quantitative Strategies first reported a position in Axonics, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
Occudo Quantitative Strategies's Axonics, Inc. Common Stock position peaked at $1.56M in Q2 2023.
220 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.